[Tiapride therapy of centrally produced dyskinesia. Examination of the serum levels of protein, LH and FSH (author's transl)]. / Zur Therapie zentralbedingter Bewegungsanomalien mit Tiaprid. Untersuchung des Serumspiegels von Prolactin, LH and FSH.
Arzneimittelforschung
; 32(3): 286-9, 1982.
Article
en De
| MEDLINE
| ID: mdl-6805485
ABSTRACT
The effect of N-(2-diethylaminoethyl)-2-methoxy-5-(methylsulfonyl)-benzamide hydrochloride (tiapride, Tiapridex), a dopamine antagonist, on the serum levels of prolactin, luteinising hormone (LH) and follicle-stimulating hormone (FSH) was studied on 20 healthy individuals and 10 patients with dyskinesia resulting from extrapyramidal disorders. Daily doses of 300 mg in healthy subjects and 300-800 mg in patients with dyskinesia resulted from CNS disorders, were found to increase serum prolactin levels without causing amenorrhoea or galactorrhoea. The drug seemed to have no effect on LH and FSH concentrations in the serum.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Prolactina
/
Clorhidrato de Tiapamilo
/
Benzamidas
/
Hormona Luteinizante
/
Hormona Folículo Estimulante
/
Trastornos del Movimiento
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
De
Revista:
Arzneimittelforschung
Año:
1982
Tipo del documento:
Article